(1-methyl-1H-pyrazol-4-yl)methanol → 4-Chloro-1-[(1-methylpyrazol-4-yl)methyl]-3,5-diphenyl-pyrazolo[3,4-c]pyridazine
반응식
[Cl:1][C:2]1[C:7]([C:8]2[CH:13]=[CH:12][CH:11]=[CH:10][CH:9]=2)=[N:6][N:5]=[C:4]2[NH:14][N:15]=[C:16]([C:17]3[CH:22]=[CH:21][CH:20]=[CH:19][CH:18]=3)[C:3]=12.[CH3:23][N:24]1[CH:28]=[C:27]([CH2:29]O)[CH:26]=[N:25]1>>[Cl:1][C:2]1[C:7]([C:8]2[CH:9]=[CH:10][CH:11]=[CH:12][CH:13]=2)=[N:6][N:5]=[C:4]2[N:14]([CH2:29][C:27]3[CH:26]=[N:25][N:24]([CH3:23])[CH:28]=3)[N:15]=[C:16]([C:17]3[CH:18]=[CH:19][CH:20]=[CH:21][CH:22]=3)[C:3]=12참가 물질
3
실험 절차
Compound IIg was synthesized from 4-chloro-3,5-diphenyl-1H-pyrazolo[3,4-c]pyridazine and (1-methyl-1H-pyrazol-4-yl)methanol following the general procedure for the Mitsunobu reaction as described above.
후처리
- customfor the Mitsunobu reaction
출처 및 근거
- ORD 기록
- ord-7891252c4ee94aae92a4b09df83c7374
- 출처 데이터셋
- uspto-grants-2016_06
- 특허 번호
- US09371332B2
반응 노트
불러오는 중…